Preclinical Aspects of HM100385 as a Novel & Non-Covalent YAP/TAZ-TEAD Inhibitor: Therapeutic Potential for Hippo-Pathway Altered Cancers
Time: 9:00 am
day: Day Two Morning
Details:
Download the Brochure to View the Session Details
